The Oncology Institute, Inc. (STLN) — Financial Flexibility Index
The Oncology Institute, Inc. (STLN) has a Financial Flexibility Index of 0.06x as of June 2026. Free cash flow of $12.85 Million (operating CF $11.94 Million minus capex $908.00K) represents 0% of total liabilities ($203.15 Million). Explore how well can The Oncology Institute, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
The Oncology Institute, Inc. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for The Oncology Institute, Inc. across 4 annual periods.
Annual Financial Flexibility Index for The Oncology Institute, Inc. (2022–2025)
Year-by-year free cash flow to debt coverage for The Oncology Institute, Inc.. For the full cash flow conversion analysis, see The Oncology Institute, Inc. cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-21.39 Million | $-24.59 Million | $180.38 Million | ▲ +11.8% |
| 2024 | -0.13x | $-22.75 Million | $-26.54 Million | $169.13 Million | ▲ +35.5% |
| 2023 | -0.21x | $-31.75 Million | $-36.31 Million | $152.22 Million | ▲ +48.6% |
| 2022 | -0.41x | $-56.23 Million | $-61.76 Million | $138.49 Million | — |